ARCHIVE
Revision as of 22:45, 7 November 2012 by Jlisiecki (talk | contribs) (New page: *QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3) ''09JUN2012'' *[[Media:QIBA FDG-PET ...)
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3) 09JUN2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7.3) 31MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.7) 23MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.6.1.8) 11MAY2012
- QIBA Profile: FDG-PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy (v0.5.9) 08Mar2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.8) 03Feb2012
- FDG-PET/CT Profile: Status Update and Plan Presentation from 02.03.2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.7) 01-16-2012
- QIBA Profile: FDG-PET as an Imaging Biomarker Predicting Response to Cancer Therapy for Oncologic Drug Development (v0.5.6) 01-08-2012
- Whole Body FDG-PET Word version of Profile applicable to multiple indications, 04-19-2011
- Whole Body FDG-PET Word version of Profile applicable to multiple indications, 03-12-2011
- Profile: FDG-PET Whole Body First version of Profile, 2009 (currently inactive)